[The use of hydroxyapatite in the surgical treatment of benign non aggressive bone lesions].
The authors studied, in the period 1990-1993, 31 patients with benign non aggressive bone lesions, surgically treated with intralesional resection followed by the introduction of hydroxyapatite. Their follow-up was two years and one month. The authors discussed the surgical indications, the operative technique employed, and the post-operative results which were considered to be good in 29 of the patients studied. Occurred complications in three patients: local infections in two and sterile fistula in one. It is concluded that the use of hydroxyapatite is a good option as substitute of the autologous bone graft.
Croci
A T
AT
Departamento de Ortopedia, Hospital das Clínicas, Faculdade de Medicina de São Paulo.
Camargo
O P
OP
Oliveira
N R
NR
Okane
S Y
SY
Campos Filho
R
R
D000293:Adolescent; D000328:Adult; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D017886:Durapatite; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D019736:Prostheses and Implants; D011859:Radiography; D016896:Treatment Outcome
D017886:Durapatite
O emprego da hidroxiapatita no tratamento cirúrgico das lesões ósseas benignas não agressivas.